Using WhatsApp chats to understand a new approach to HIV testing in children.
Published in Healthcare & Nursing
Improving HIV testing for children and adolescents is vitally important, because children and adolescents experience a disproportionate amount of HIV-related illness and death compared to adults. Although children and adolescents aged up to 19 years old were only 7% of the global population living with HIV in 2021, they represented 17% of HIV-related deaths. This is due, in part, to late diagnosis of HIV.
A new approach to finding undiagnosed children living with HIV, known as index-linked testing, has been recommended by the World Health Organisation to improve diagnosis rates. Index-linked testing involves targeting of HIV testing to children of people living with HIV (known as indexes). This focused approach has the potential to find more children living with HIV and be more cost-effective than blanket testing approaches.
The “Bridging the Gap in HIV Testing and Care for Children in Zimbabwe” (B-GAP) study evaluated index-linked HIV testing for children aged between two and 18 years old at nine primary care clinics, covering both rural and urban areas. People living with HIV in a household with one or more children of unknown HIV status, or with a known HIV negative result more than 6 months ago, were eligible to take part in the study. Those who consented to have children tested could choose either a test at the clinic, a test at home delivered by a community healthcare worker (HCW), or a test at home delivered by a caregiver using an oral HIV self-test. B-GAP provided an opportunity to examine implementation in-depth, so lessons could be learned for future roll-out.
The B-GAP team kept in touch via two long-running WhatsApp chats, one for the whole field team, and the other for the rural areas only. We used those WhatsApp chats, as well as field team logs, meeting minutes, and incident reports, to identify barriers and facilitators to scale-up of index-linked testing. Data from each source was analysed thematically.
The WhatsApp chats deepened our understanding of implementation. In the chats, the team often offered more comprehensive opinions on successes and challenges than in other sources. For example, one chat had detailed discussion on difficulties coordinating with partner organisations who were delivering HIV testing of children in the community. This clarified the underlying reasons why these challenges were occurring, such as differences in aims between the partner organisations and the research team, as well as resource constraints faced by partner organisations. The chats also provided a real-time and dynamic account of events, such as stock-outs of HIV test kits, over time.
However, WhatsApp chats required more effort to analyse than the other sources. As the chats were an informal record, sometimes it was challenging to work out what researchers were referring to in their messages. Unlike with the other sources, the team presumed readers had prior knowledge of what was being discussed, making it difficult for an outsider to follow the conversation. Moreover, sometimes researchers met face-to-face or communicated using other technology, which led to sudden jumps in the topics being covered in the chats.
Nonetheless, through analysing the WhatsApp chats and other sources, we identified a range of challenges to index-linked testing for children. These are illustrated in the flow diagram to the right. Some challenges were recognised barriers to provision of many forms of HIV testing, such as stock-outs of HIV test kits, difficulties reaching clinics, and stigma around HIV. However, we also identified some unexpected challenges, such as indexes sending someone else to the clinic on their behalf, and a lack of familiarity with oral HIV testing, which resulted in low uptake. As index-linked HIV testing for children is used more widely it will be critical to find ways to ensure these challenges can be overcome.
The WhatsApp chats gave us valuable insight into the barriers and facilitators of index-linked HIV testing. It is important to consider newer technologies and social media alongside traditional sources of data to fully capture the complexity of implementation of public health interventions. By doing so, we can more effectively address barriers to delivery of interventions and ultimately improve health outcomes.
Read more about the B-GAP study and its findings in the following publications:
- Delivery of index-linked HIV testing for children: learnings from a qualitative process evaluation of the B-GAP study in Zimbabwe
- Comparison of index-linked HIV testing for children and adolescents in health facility and community settings in Zimbabwe: findings from the interventional B-GAP study
- Addressing the challenges and relational aspects of index-linked HIV testing for children and adolescents: insights from the B-GAP study in Zimbabwe
- Feasibility and Accuracy of HIV Testing of Children by Caregivers Using Oral Mucosal Transudate HIV Tests
Katherine is a PhD student at Imperial College London. Her PhD focuses on the links between HIV, mental health, and quality of life in sub-Saharan Africa.
Follow the Topic
-
BMC Infectious Diseases
This journal is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of infectious and sexually transmitted diseases in humans, as well as related molecular genetics, pathophysiology, and epidemiology.
Related Collections
With Collections, you can get published faster and increase your visibility.
Infectious disease management in infants and children
BMC Infectious Diseases invites submissions for a Collection on Infectious diseases in infants and children.
Infectious diseases in infants and children represent a significant burden on healthcare systems globally, often leading to serious complications, long-term health issues, and even mortality. This Collection aims to explore the diverse range of infectious diseases that specifically affect the pediatric population, including but not limited to respiratory infections, gastrointestinal infections, and vaccine-preventable diseases. Understanding the unique immune responses and vulnerabilities of young children is crucial for developing effective prevention and treatment strategies tailored to their needs.
The continued research into pediatric infectious diseases is vital for several reasons. Advances in immunization have significantly reduced the incidence of many vaccine-preventable diseases; however, challenges remain, particularly with the emergence of antimicrobial resistance and the resurgence of certain infections. Furthermore, the COVID-19 pandemic has underscored the importance of infection control measures in childcare, preschool, and school settings and highlighted the need for ongoing surveillance of childhood diseases. This area of research promises to contribute to improved health outcomes for infants and children worldwide.
With sustained research efforts, we can anticipate significant advances in the future, including the development of novel vaccines, improved diagnostics, and tailored treatment protocols. Continued exploration of the epidemiology of childhood diseases will further enhance our understanding of transmission dynamics and inform public health interventions.
We invite pediatricians, infectious disease specialists, public health professionals, immunologists, epidemiologists, and researchers in related fields to contribute original research articles on topics including but not limited to:
- Pediatric infectious diseases and their management
- Early childhood immunity and its implications
- Epidemiology of respiratory infections in children
- Antimicrobial resistance trends in pediatric settings
- Infection control in childcare, preschool, and school settings
This Collection supports and amplifies research related to SDG 3: Good Health and Well-being.
All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.
Publishing Model: Open Access
Deadline: Jun 30, 2026
Tuberculosis immunology and infection
BMC Infectious Diseases invites submissions for a Collection on Tuberculosis immunology and infection.
Tuberculosis (TB) remains a global health challenge, with millions affected by Mycobacterium tuberculosis each year. The interplay between the bacterium and the host's immune response is complex, involving various cellular and molecular mechanisms that determine the outcome of infection. Understanding the immunological aspects of TB is crucial for developing effective diagnostics, therapeutics, and vaccines. This Collection aims to explore the latest research on TB immunology, pathogenesis, and infection dynamics, shedding light on both latent and active TB states.
The significance of this research lies in its potential to inform public health strategies and interventions. Recent advances in immunological research and vaccine development have demonstrated promising avenues for tackling TB, including novel biomarkers for diagnosis and innovative vaccine candidates. Furthermore, the integration of genomic and proteomic technologies has provided deeper insights into the host-pathogen interactions, paving the way for more effective treatments and preventive measures. Continued focus on TB immunology will be vital in the global fight against this disease.
As research progresses, we anticipate breakthroughs that could transform TB management, including personalized vaccine strategies and targeted immunotherapies. The continued exploration of the immune response to TB may also yield critical insights into preventing reactivation of latent infections, ultimately contributing to the goal of TB eradication.
- Immune response to Mycobacterium tuberculosis
- Pathogenesis of latent and active TB
- Advances in TB vaccine development
- Novel diagnostic approaches for TB
This Collection supports and amplifies research related to SDG 3: Good Health and Well-being.
All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.
Publishing Model: Open Access
Deadline: Mar 31, 2026
Please sign in or register for FREE
If you are a registered user on Research Communities by Springer Nature, please sign in